Destination: Cure

Step by Step At CROI 2017, HIV remission studies focus on early antiretroviral therapy initiation by Jeannie Wraight This year marked the 24th annual Conference on Retroviruses...

Buyer Beware The new administration may threaten HIV care and cure research by Jeannie Wraight Our way of life in the U.S. has already drastically changed as...

Hide & Seek Paul Volberding, MD, helps create synergy at the amfAR Institute for Cure Research by Jeannie Wraight The amfAR Institute for HIV Cure Research was...

Hiding Place One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs by Jeannie Wraight This year, amfAR marked World AIDS Day with the 2016 HIV...

Beyond One Bug, One Drug Broad spectrum antivirals shift the drug model paradigm, part II by Jeannie Wraight In the October issue of A&U, Destination: Cure explored...

Spectrum Analysis Broad spectrum antivirals shift the drug model paradigm by Jeannie Wraight The recent spread of emerging pandemic viruses such as Zika and Ebola has increased...

Step Forward Vaccine candidates like HTVN 702 are needed to build momentum by Jeannie Wraight If current HIV diagnoses rates persist, about 1 in 2 black men...

Oral Report Could something as simple as oral care affect viral reservoirs? by Jeannie Wraight Research performed at Case Western found increased levels of HIV in the...

Sometimes viewing a complex issue in its most simplistic form can help us to understand where a problem lies. HIV is a virus that...

Another year of the Conference on Retroviruses and Opportunistic Infections (CROI 2016) has come to pass. Here are a few less publicized but important...